Related Experiment Videos
Managing Cancer And Living Meaningfully: study protocol for a randomized controlled trial
Chris Lo1,2, Sarah Hales3,4, Anne Rydall5
1Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 16th Floor, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. chris.lo@utoronto.ca.
Trials
|September 4, 2015
Summary
This study tested Managing Cancer And Living Meaningfully (MACL) for advanced cancer patients. The intervention aims to reduce distress and improve well-being, with results to be determined.
Area of Science:
- Psychotherapeutic interventions
- Oncology
- Psychosocial oncology
Background:
- A novel brief psychotherapeutic intervention, Managing Cancer And Living Meaningfully (MACL), was developed for advanced cancer patients.
- Distress and reduced well-being are significant challenges for individuals with advanced or metastatic cancer.
Purpose of the Study:
- To describe the methodology of a randomized controlled trial (RCT) evaluating the efficacy of the MACL intervention.
- To assess the potential of MACL to alleviate distress and promote psychological well-being in patients with advanced cancer.
Main Methods:
- An unblinded RCT comparing MACL plus usual care versus usual care alone.
- The study includes 3-6 sessions delivered over 3-6 months, with assessments at baseline, 3, and 6 months.
- Primary outcome is depressive symptom frequency; secondary outcomes include anxiety, quality of life, and spiritual well-being.
Main Results:
- Primary endpoint for depressive symptoms is at 3 months.
- Secondary outcomes assess a range of psychological and quality-of-life indicators.
- Results are pending as the trial is ongoing.
Conclusions:
- The MACL intervention shows potential for relieving distress and enhancing psychological well-being in advanced cancer patients and their caregivers.
- The RCT aims to determine the clinical benefit of MACL and inform its future dissemination.
- The intervention has international relevance, with training conducted across multiple continents.
Related Concept Videos
Cancer Survival Analysis
838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies
3.0K
3.0K